Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 12(1): 17, 2022 01 07.
Article in English | MEDLINE | ID: mdl-34996979

ABSTRACT

Monoamine oxidase (MAO) is a key enzyme responsible for the degradation of neurotransmitters and trace amines. MAO has two subtypes (MAO-A and MAO-B) that are encoded by different genes. In the brain, MAO-B is highly expressed in the paraventricular thalamic nucleus (PVT); however, its substrate in PVT remains unclear. To identify the MAO-B substrate in PVT, we generated Maob knockout (KO) mice and measured five candidate substrates (i.e., noradrenaline, dopamine, 3-methoxytyramine, serotonin, and phenethylamine [PEA]) by liquid chromatography tandem mass spectrometry. We showed that only PEA levels were markedly elevated in the PVT of Maob KO mice. To exclude the influence of peripheral MAO-B deficiency, we developed brain-specific Maob KO mice, finding that PEA in the PVT was increased in brain-specific Maob KO mice, whereas the extent of PEA increase was less than that in global Maob KO mice. Given that plasma PEA levels were elevated in global KO mice, but not in brain-specific KO mice, and that PEA passes across the blood-brain barrier, the substantial accumulation of PEA in the PVT of Maob KO mice was likely due to the increase in plasma PEA. These data suggest that PEA is a substrate of MAO-B in the PVT as well as other tissues.


Subject(s)
Midline Thalamic Nuclei/enzymology , Monoamine Oxidase/metabolism , Phenethylamines/metabolism , Animals , Dopamine/analogs & derivatives , Dopamine/metabolism , Female , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Midline Thalamic Nuclei/chemistry , Midline Thalamic Nuclei/metabolism , Monoamine Oxidase/chemistry , Monoamine Oxidase/genetics , Neurotransmitter Agents/metabolism , Norepinephrine/metabolism , Serotonin/metabolism , Substrate Specificity
2.
Nat Commun ; 11(1): 2501, 2020 05 19.
Article in English | MEDLINE | ID: mdl-32427844

ABSTRACT

Anxiety is common in patients suffering from chronic pain. Here, we report anxiety-like behaviors in mouse models of chronic pain and reveal that nNOS-expressing neurons in ventromedial prefrontal cortex (vmPFC) are essential for pain-induced anxiety but not algesia, using optogenetic and chemogenetic strategies. Additionally, we determined that excitatory projections from the posterior subregion of paraventricular thalamic nucleus (pPVT) provide a neuronal input that drives the activation of vmPFC nNOS-expressing neurons in our chronic pain models. Our results suggest that the pain signal becomes an anxiety signal after activation of vmPFC nNOS-expressing neurons, which causes subsequent release of nitric oxide (NO). Finally, we show that the downstream molecular mechanisms of NO likely involve enhanced glutamate transmission in vmPFC CaMKIIα-expressing neurons through S-nitrosylation-induced AMPAR trafficking. Overall, our data suggest that pPVT excitatory neurons drive chronic pain-induced anxiety through activation of vmPFC nNOS-expressing neurons, resulting in NO-mediated AMPAR trafficking in vmPFC pyramidal neurons.


Subject(s)
Chronic Pain/enzymology , Chronic Pain/psychology , Midline Thalamic Nuclei/enzymology , Neurons/enzymology , Nitric Oxide Synthase Type I/metabolism , Prefrontal Cortex/enzymology , Animals , Anxiety , Behavior, Animal , Chronic Pain/genetics , Humans , Male , Mice , Mice, Inbred C57BL , Midline Thalamic Nuclei/cytology , Neurons/cytology , Nitric Oxide/metabolism , Nitric Oxide Synthase Type I/genetics , Prefrontal Cortex/cytology
3.
J Neuroendocrinol ; 18(8): 621-8, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16867183

ABSTRACT

In addition to the classical direct genomic mechanisms of action, oestrogen also exerts poorly understood, nonclassical effects on the signalling system in neurones. In the present study, we investigated whether sex differences exist in gonadectomy- and oestrogen-induced effects on p44/42 mitogen-activated protein kinase (MAPK) phosphorylation in specific brain regions of mice. We demonstrate that MAPK immunoreactivity was not altered by gonadectomy or oestrogen treatment in either sex. However, we show that the level of phosphorylated MAPK (pMAPK) within the anteroventral periventricular nucleus (AVPV) was consistently higher in males than females irrespective of gonadal steroid hormone status. In addition, gonadectomy was found to decrease pMAPK immunoreactivity within the piriform cortex of males. Oestrogen increased pMAPK immunoreactivity in the medial preoptic area and AVPV of females, but failed to have the same effect in male mice. Overall, these results demonstrate a marked sex difference in oestrogen-induced alteration of MAPK phosphorylation in the brain in vivo.


Subject(s)
Brain/enzymology , Estrogens/physiology , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , Analysis of Variance , Animals , Castration , Cerebral Cortex/enzymology , Female , Immunohistochemistry , Luteinizing Hormone/blood , Male , Mice , Mice, Inbred C57BL , Midline Thalamic Nuclei/enzymology , Ovariectomy , Phosphorylation , Preoptic Area/enzymology , Sex Factors
4.
J Neuroendocrinol ; 14(12): 971-8, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12472878

ABSTRACT

In male rodents, the arginine-vasopressin-immunoreactive (AVP-ir) neurones of the bed nucleus of the stria terminalis (BNST) and medial amygdala are controlled by plasma testosterone levels (decreased after castration and restored by exogenous testosterone). AVP transcription in these nuclei is increased in adulthood by a synergistic action of the androgenic and oestrogenic metabolites of testosterone and, accordingly, androgen and oestrogen receptors are present in both BNST and medial amygdala. We used knockout mice lacking a functional aromatase enzyme (ArKO) to investigate the effects of a chronic depletion of oestrogens on the sexually dimorphic AVP system. Wild-type (WT) and ArKO male mice were perfused 48 h after an i.c.v. colchicine injection and brain sections were then processed for AVP immunocytochemistry. A prominent decrease (but not a complete suppression) of AVP-ir structures was observed in the BNST and medial amygdala of ArKO mice by comparison with the WT. Similarly, AVP-ir fibres were reduced in the lateral septum of ArKO mice and but not in the medial preoptic area, a region where the AVP system is not sexually dimorphic in rats. No change was detected in the supraoptic and suprachiasmatic nuclei. However, a decrease in AVP-ir cell numbers was however, detected in one subregion of the paraventricular nucleus. These data support the hypothesis that the steroid-sensitive sexually dimorphic AVP system of the mouse forebrain is mainly under the control of aromatized metabolites of testosterone.


Subject(s)
Arginine Vasopressin/metabolism , Aromatase/metabolism , Animals , Aromatase/genetics , Colchicine/administration & dosage , Colchicine/pharmacology , Immunohistochemistry , Injections, Intraventricular , Male , Mice , Mice, Knockout , Midline Thalamic Nuclei/cytology , Midline Thalamic Nuclei/enzymology , Midline Thalamic Nuclei/metabolism , Neurons/metabolism
5.
Brain Res ; 913(2): 159-64, 2001 Sep 21.
Article in English | MEDLINE | ID: mdl-11549380

ABSTRACT

We examined protein kinase C gamma-like immunoreactivity (PKCgamma-LI) of trigeminothalamic neurons in the rat medullary dorsal horn (MDH) after injecting a retrograde tracer, Fluoro-Gold (FG), into the thalamus. Over 90% of FG-labeled neurons in the marginal layer (lamina I) and a few FG-labeled neurons in the superficial part of the magnocellular layer (lamina III) showed PKCgamma-LI. No PKCgamma-neurons in the substantia gelatinosa (lamina II) were labeled with FG. PKCgamma-mediated regulation of trigeminothalamic neurons may contribute to the changes in MDH activity during persistent pain.


Subject(s)
Isoenzymes/metabolism , Neural Pathways/enzymology , Neurons/enzymology , Pain/enzymology , Protein Kinase C/metabolism , Signal Transduction/physiology , Thalamus/enzymology , Trigeminal Caudal Nucleus/enzymology , Animals , Cell Count , Immunohistochemistry , Intralaminar Thalamic Nuclei/cytology , Intralaminar Thalamic Nuclei/enzymology , Male , Midline Thalamic Nuclei/cytology , Midline Thalamic Nuclei/enzymology , Neural Pathways/cytology , Neurons/cytology , Pain/physiopathology , Posterior Thalamic Nuclei/cytology , Posterior Thalamic Nuclei/enzymology , Rats , Rats, Sprague-Dawley , Receptors, Neurokinin-1/metabolism , Substance P/metabolism , Substantia Gelatinosa/cytology , Substantia Gelatinosa/enzymology , Synaptic Transmission/physiology , Thalamus/cytology , Trigeminal Caudal Nucleus/cytology , Ventral Thalamic Nuclei/cytology , Ventral Thalamic Nuclei/enzymology
SELECTION OF CITATIONS
SEARCH DETAIL
...